Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Effects on Fear and RAGE Polymorphism
NCT04292444Phase 1Unknown
- Sponsor
- University Hospital Bonn
- Start
- Dec 2019
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in anxiety disorder (2 arms), sponsored by University Hospital Bonn. Primary endpoints: Blood-oxygen-level dependent signal in the amygdala and striatum, Neural responses in the flight initiation distance (FID) task and 2 more. Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04292444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04292444.